AbbVie Inc. is 193.1x more valuable than Harmony Biosciences Holdings, Inc. by market capitalization ($399.47 B vs $2.07 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | HRMY | ABBV |
|---|---|---|
| Market cap | $2.07 B | $399.47 B |
| US-listed rank | #2075 | #28 |
| Revenue (latest FY) | $868.45M | $61.16B |
| Net income (latest FY) | $158.69M | $4.23B |
| Net margin | 18.3% | 6.9% |
| P/E (trailing FY) | 13.0 | 94.5 |
| SEC filings | 434 | 1,008 |
AbbVie Inc. is 193.1x more valuable than Harmony Biosciences Holdings, Inc. by market capitalization ($399.47 B vs $2.07 B).
In their latest fiscal years, Harmony Biosciences Holdings, Inc. reported $868.45M in revenue while AbbVie Inc. reported $61.16B.
Full pages: Harmony Biosciences Holdings, Inc. and AbbVie Inc., or browse the full rankings.